GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
GRAIL (Nasdaq: GRAL) said company management will present at the TD Cowen 46th Annual Health Care Conference in Boston on Mar. 3, 2026 at 10:30 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
GRAIL (Nasdaq: GRAL) said company management will present at the TD Cowen 46th Annual Health Care Conference in Boston on Mar. 3, 2026 at 10:30 a.m. ET.
Live and replay webcasts will be available via the company's investor relations website and archived for at least 30 days after the event.
Details
News Market Reaction – GRAL
On Feb 25, the first trading day after this news, GRAL closed 2.86% above the previous close.
Data tracked by StockTitan Argus for the Feb 25 session.
Key Figures
- Conference date
- March 3
- TD Cowen 46th Annual Health Care Conference presentation date
- Presentation time
- 10:30 a.m. ET
- Scheduled time for management presentation
- Webcast availability
- 30 days
- Archived replay period after the event
Historical Context
-
Reported 2025 results with revenue growth but sizable net losses and cash runway.
-
Released NHS-Galleri topline data with mixed endpoint outcome and detection benefits.
-
Submitted final PMA module to FDA for Galleri multi-cancer early detection test.
-
Planned corporate update at the 44th Annual J.P. Morgan Healthcare Conference.
-
Announced inducement RSU grants to recent hires under Nasdaq Listing Rule 5635(c)(4).
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-td-cowen-46th-annual-health-care-conference-302696206.html
SOURCE GRAIL, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.